Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Phil Wieland is the CEO of Diversey Holdings
Recent Videos
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper
Suggestions
00:10:00
The problem is that it’s hard to assess management without being able to look them in the eye and ask the questions that matter to you|Paddy Nicol, President, CEO and Director of Orogen Royalties Inc
00:10:00
Invisio Communations Presents at ABGSC Investor Days | Lars Højgård Hansen - CEO of INVISIO AB
00:10:00
The Importance of Fact-Based Policy for American Voters|Michael Boskin
00:10:00
Midas Gold Highlights Idaho Gold Project at One-to-One Mining Investment Conference
00:10:00
Presenting at Redeye Technology Day 2018 is CEO Joonhee Won | Joonhee Won, CEO, Anoto Group ABANOT:STO
00:10:00
Gold as an Inflation Hedge: Expert Insights | Edison Byzyka - Chief Investment Officer at Credent Wealth Management
00:10:00
Or Yissachar on IDF Insights and Challenges Facing Israel|Or Yissachar, Professor, Paris School of International Affairs
00:10:00
Investing in Innovation: Vanguard Health Care Fund with Jean Hynes | Jean Hynes - CEO, Wellington Management
00:10:00
Building Resilient Companies: Insights from Lei Zhang on Thriving in Challenging Times | Zhang Lei, CEO , Hillhouse Capital Group.
00:10:00
Eric's Journey from Product Management to Award-Winning CMO at Infinidat
00:10:00
Navigating Fund Structures: Understanding ILPA's Whole of Fund Waterfall Model | Steve Balaban, CFA
00:00:00
Tissue Regenix Group "has the opportunity to become a global commercial organisation" - Danny Lee, CEO, Tissue Regenix Group